Manuel C. D.
- Country
- Italy
- Department
- Medical Oncology
Research Overview
- A Phase III, Randomized, Double-Blinded, Placebo-Controlled Study of Tiragolumab, an Anti-Tigit Antibody, in Combination with Atezolizumab Compared with Placebo in Combination with Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
- Evaluation of Debio 0123 Combined with Carboplatin and Etoposide in Adults with Recurrent or Progressive Small Cell Lung Cancer Post-Platinum Therapy
- A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab, with or without Platinum Chemotherapy, in Subjects with No Prior Therapy for Advanced or Metastatic PD-L1 TPS<50% Non-squamous Non-small Cell Lung Cancer without Actionable Genomic Alterations (TROPION-Lung07)
Data & Insights
Has run more than one trial at 543 of 842 partner sites.
Specializations
Lung Cancer Focus
This investigator specializes in the treatment of non-small cell lung cancer (NSCLC), with particular emphasis on both early-stage and advanced disease states. Their research encompasses various stages of NSCLC, including metastatic and locally advanced cases.
- Non-squamous NSCLC treatments
- Advanced stage disease management
- Post-surgical adjuvant therapy
Therapeutic Approaches
The investigator works extensively with immunotherapy-based treatments and their combinations. Their research includes evaluation of novel antibody-drug conjugates and targeted therapies for various cancer indications.
- Combination immunotherapy protocols
- Novel therapeutic antibodies
- Comparative treatment efficacy
Additional Oncology Areas
Beyond lung cancer, the investigator conducts research in other oncological fields, including melanoma and solid tumor treatments. Their work extends to head and neck cancer and prostate cancer therapies.
- Advanced solid tumors
- Metastatic disease management
- Multi-cancer treatment protocols
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.